Tiziana Life Sciences Share Discussion Threads

[impala391] 02/10/2015 17:49

Agree ic, a very positive report. The miliciclib trials have been extended to April 2016.
So news of the candidate going forward to trials is now imminent .

[andrbea] 16/9/2015 14:21

some companies working in same sector & market size:

sector:
anti-cancer agent which targets cancer stem cells

The global metastatic pancreatic cancer drug market is estimated to be US$1.2 billion in 2015. In 2015, the CDC estimates that there will be approximately 49,000 new cases of metastatic pancreatic cancer in the United States. For pancreatic cancer patients overall, the five-year survival rate is approximately 7% for all stages combined and only 2% for patients with metastatic pancreatic cancer, according to the U.S. National Cancer Institute. Studies have found that the median overall survival span for metastatic pancreatic cancer patients ranges from approximately eight to 11 months. Although there are a number of approved drugs for the treatment of metastatic pancreatic cancer, there continues to be a significant unmet medical need.



also:


Emerging strategies for cancer immunoprevention
Nature.com-14 Sep 2015
Less than a dozen chemopreventive agents have been FDA .... IL-6 regulates normal and tumor stem cell self-renewal through Notch-3 ... which creates a permissive environment for breast cancer stem cells survival in hypoxic conditions. ... The antitumor effects reported were mostly described in the setting ...

[andrbea] 04/9/2015 11:55

The favoured scenario is for a one month move to 270p at the February resistance line. - See more at:

[jpuff] 02/9/2015 17:08

Haven't sold any during the correction and reckon great things could've round the corner here GLA

[andrbea] 02/9/2015 17:06

heading north again, back to intra-day 220p?

[rovi70] 21/8/2015 12:08

Exciting times a coming me thinks.

[stenick] 21/8/2015 12:00

News released 20th Jan 2015.
Nerviano has shown in preclinical studies that milciclib has potential in other cancer indications, in particular liver cancer and breast cancer, for which potential biomarkers of response have been identified and which will support the clinical development in these indications planned to start in 2015. Tiziana plans to immediately enrol patients into a new phase II trial in hepatocellular carcinoma using a protocol already prepared by Nerviano, and will explore the potential for an additional phase II trial in breast cancer.

Didn't realise that Tiziana is doing another Phase 11 trial !
Lots of news to come.

[saturn5] 18/8/2015 16:48

Why is share price falling ?

[stenick] 18/8/2015 14:06

hxxp://adisinsight.springer.com/drugs/800026196
Looks like Phase 11 trial of miliciclib is complete.
News to come.

[wageslave] 08/8/2015 15:09

Lack of stock availability has created a very tight market that responds to low volume buying and selling activity. Still looks positive near term imho as sells get mopped up quickly.

[sharestobuy] 08/8/2015 14:25

Can someone explain why this has had a gradual upward trend since its was 50p ish. I'm new here and I need to know more before considering investing. Was hoping one of you could fill me in?

[roper] 30/7/2015 11:20

Pretty much bid only the broker link :-) GLA

[sos100] 30/7/2015 09:44

super stock and bucking the trend in these awful markets

wish i held on!

[impala391] 21/7/2015 07:22

Found this , it sums up TILS pretty well sofar.
hxxp://equitydevelopment.co.uk/doc/1313.pdf

[impala391] 11/7/2015 11:45

Seems to float well, plenty of news to come!

[andrbea] 19/6/2015 12:20

maybe lowered from 209p because that big buyer (51k pounds) wants some more at ca 200p... just guessing

[jpuff] 18/6/2015 16:58

Broken out of rising wedge

[andrbea] 18/6/2015 16:47

£ 51 840, not exactly pocket money, is it...

[jpuff] 18/6/2015 16:02

A buy of 27,000 shares at 192p nice sign of commitment

[andrbea] 17/6/2015 14:06

Scientists discover cancer-killing compound

Scientists are one step closer in their fight against cancer as they discover a compound which can target cancer tumours

////

Scientists have developed a new anti-cancer stem cell agent capable of targeting aggressive tumour forming cells common to breast, pancreas, colon and prostate cancers.

The new compound, known as OH14, is capable of eradicating a number of different kinds of cancer cells, including cancer stem cells from breast cancer biopsies.

[andrbea] 17/6/2015 09:50

some alliances appearing on CDK research, that would be the ultimate goal of TILS one assumes, to have an alliance with a big US pharma giant


LDC and Qurient Close Licence Agreement on Novel Anti-cancer Compound